Company: Visterra, Inc.
Job title: Executive Director, Research
Precision Antibody-Based Therapeutics for Complement Regulation 3:00 pm
Targeting critical components of the complement pathway can impact diseases that are initiated or exacerbated by complement dysregulation Antibody based therapeutics can be used to precisely target and potently inhibit complement activation Visterra has developed novel antibodies for targeting complement activationRead more
day: Track A - Day 1 PM